Science Corner


ATSDR Biennial Report to Congress 1991 and 1992


(Note: Only the Executive Statement of the Biennial Report to Congress is available in this file.)

This biennial report covers the period from January 1, 1991, through December 31, 1992, and is the third submitted by the Secretary of the Department of Health and Human Services (DHHS) to the Congress and to the Administrator of the Environmental Protection Agency (EPA). It is submitted in accordance with Section 104(i)(10) of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA), also known as Superfund), as amended by the Superfund Amendments and Reauthorization Act (SARA) of 1986, which requires the Agency to publish a report on its programs and operations every 2 years.

EXECUTIVE STATEMENT

As part of its assigned responsibilities under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA or Superfund), as amended, the Agency for Toxic Substances and Disease Registry (ATSDR) is required to prepare a biennial report to Congress that fulfills the following objectives:

Determining the relationship between releases of hazardous substances into the environment and effects on human health is a challenging responsibility. Such investigations are often hindered by lack of toxicologic characterization of substances released from hazardous waste sites, limited knowledge about timing and extent of exposure, and uncertainties regarding the size of the populations at risk. Despite these hindrances, comprehensive review by the National Research Council (NRC) of the published literature on the public health implications of hazardous waste (1) concluded that "...several investigations at specific sites have documented a variety of symptoms of ill health in exposed persons, including low birth weight, cardiac anomalies, headache, fatigue, and a constellation of neurobehavorial problems. It is less clear whether outcomes with a long delay between exposure and disease also have occurred because of complex methodological problems in assessing these outcomes. However, some studies have detected excesses of cancer in residents exposed to compounds such as those that occur at hazardous waste sites."

Findings available to ATSDR subsequent to the release of the NRC report further demonstrate that, for some sites, an association exists between the release of hazardous substances and some human health effects. This conclusion is supported by data from two major sources: human health studies and analysis of ATSDR's public health assessments and toxicological profiles.

A number of health studies completed within the past few years most clearly demonstrate the association between hazardous substances and illness. In addition, analysis of public health assessments and toxicological profile data contained in ATSDR's HazDat database illustrate that 1) people are, in fact, being exposed to hazardous substances from a variety of waste sites and unplanned releases, and 2) the health effects described in toxicological profiles for the most commonly encountered hazardous waste site contaminants coincide with the increased health effects observed at elevated rates in people who live or work near hazardous waste sites.

Highlights of these analyses are discussed in this Executive Statement; a more detailed discussion follows in Chapter One.

FINDING:

Human health studies have shown that adverse health effects have occurred in persons exposed to hazardous substances released from some waste sites.

FINDING:

People are being exposed to hazardous substances from a variety of sites and unplanned releases.

FINDING:

By analyzing all existing data for hazardous waste sites and the most commonly encountered substances at those sites, ATSDR has determined where and how people are most likely to be exposed to substances from those sites and the adverse health effects most likely to result.

FUTURE DIRECTIONS FOR ATSDR

The public health implications of this new information confirm many of the program decisions ATSDR has made for directing future health studies and substance-specific research. In addition, the findings point ATSDR in the new directions discussed in the following paragraphs.

Focus Efforts on Assessing Potential Environmental Causes of Some Chronic Diseases

On the basis of previous analyses of the adverse health outcomes expected from exposures to hazardous waste site contaminants, ATSDR has defined seven priority health conditions for additional research. Studies of exposed populations and analysis of exposures described in public health assessments clearly corroborate the priority health conditions chosen. Furthermore, these analyses indicate that environmental exposures may be linked with a number of chronic diseases that appear to be increasing.

For each priority health condition, a battery of clinical tests and biologic markers of exposure, susceptibility, and effect are being developed and will be applied to future health studies of populations exposed to hazardous waste. This will aid in the collection of consistent and appropriate health data and also allow for combining data from multiple studies.

The seven priority health conditions defined by ATSDR are these (alphabetical order):

Fill Data Gaps for the Most Commonly Encountered Contaminants

A small number of contaminants are involved in a large percentage of the exposures that occur, and it is likely that ATSDR does not yet know all of the adverse health effects that could be caused by these exposures. For example, a review of key data needs that have been identified for 38 of the most commonly encountered hazardous waste site contaminants revealed a lack of fundamental data on reproductive, neurologic, and immunologic toxicity. In addition, information about human exposure levels and the bioavailability of particular chemicals (e.g., how much mercuric sulfide in soil will be absorbed by the body) is also missing for these high-priority hazardous substances. For some of the most commonly encountered substances, too few studies have been conducted to allow confident derivation of the minimal risk levels (MRLs) needed to assess whether people are being exposed to levels that might cause adverse health effects.

Because of these data gaps, health effects in exposed populations may be overlooked. It is imperative that the key data gaps for these commonly encountered hazardous substances be filled.

Emphasize the Collection of Human Health Effects Data Using Persons Listed on ATSDR's Exposure Registries and Other Populations Known to Have Been Exposed to Commonly Occurring Waste Site Contaminants

Key human health effects data are lacking for virtually all of the hazardous substances found at waste sites. ATSDR exposure registries provide the raw material for generating much of this needed data.

The need to conduct health studies of these and other exposed populations will be determined using knowledge about the chemicals to which Americans are most often exposed and the adverse health effects that are most likely to result. This approach will allow ATSDR to achieve, with available resources, the greatest human health benefit in the least amount of time.

Continue Developing Essential Data for Hazardous Substances Released Infrequently

Many sites have unique contaminants that potentially affect health at only one or two sites in the country. Although the frequency of any one of these unique contaminants may be low, their frequency as a class is high, and many people may be affected. Therefore, ATSDR will continue to develop profiles that enhance assessment of the public health effects of substances that are found at few sites.

ATSDR is considering using specific analytic methods and computer models to develop essential data for these less frequently encountered substances. For example, structure activity relationship modeling can be used to predict the effects on and behavior in the environment of unstudied chemicals, using what is known about similar chemicals. Also, computer models (e.g., pharmacokinetic, pharmacodynamic, or dosimetry models) can be used to supplement and extend the usefulness of available information for a chemical.

Consider the Potential Toxic Effects of Commonly Occurring Combinations of Substances

People may be exposed to multiple substances at many waste sites, complicating diagnosis of resulting health effects. Furthermore, because of the frequency of the identification of combinations of substances at sites, the potential health effects of specific combinations may be of greater potential health concern for the nation as a whole than the effects associated with many individual substances. ATSDR will assess the health hazards of hazardous substance combinations, beginning with frequently occurring combinations.

Develop Consistent and Efficient Approaches to Hazardous Substance Releases on the Basis of Past Experience

Thousands of different hazardous substances are released under a wide variety of conditions and in a wide variety of communities, causing a vast array of different potential exposures and health effects. However, predictable patterns are associated with the types of sites involved in releases, the chemicals released, the ways the chemical move in the environment, the sizes of populations exposed to the chemicals, and the health effects that may result.

ATSDR will develop strategies that exploit these patterns to improve the efficiency and efficacy of its response to hazardous substance releases. For example, health assessors will draw upon past experience at any similar site as a starting point for new sites, thereby reducing response time and providing consistent approaches to sites across the nation.

ATSDR's HazDat database will simplify the development of such strategies and facilitate their implementation.


Footnote 1. In this context, a concentration of concern is the concentration of a substance in air, water, or soil that corresponds to a minimal risk level (MRL) as defined by ATSDR or a reference dose (RfD), reference concentration (RfC), or a one-in-a million risk of cancer as defined by EPA. It should be noted that the MRL is defined as a level "without an appreciable risk of noncancer adverse health effects." (See the definition of MRL in the glossary for a discussion of what health effects may be expected if a concentration of concern is exceeded, as well as a discussion of the uncertainty inherent in estimating MRLs.)


Link to ATSDR Science Corner


ATSDR Home Page
Charlie Xintaras / chx1@cdc.gov